Palla Pharma Ltd
ASX:PAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Oil Refineries Ltd
OTC:OILRF
|
IL |
|
Aarey Drugs and Pharmaceuticals Ltd
NSE:AAREYDRUGS
|
IN |
Palla Pharma Ltd
Revenue
Palla Pharma Ltd
Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Palla Pharma Ltd
ASX:PAL
|
Revenue
AU$16.8m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Revenue
AU$3.7m
|
CAGR 3-Years
20%
|
CAGR 5-Years
245%
|
CAGR 10-Years
0%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Revenue
AU$3.2m
|
CAGR 3-Years
20%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Revenue
AU$166.5m
|
CAGR 3-Years
16%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Revenue
AU$15.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
5%
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Revenue
AU$66.9m
|
CAGR 3-Years
65%
|
CAGR 5-Years
31%
|
CAGR 10-Years
N/A
|
|
Palla Pharma Ltd
Glance View
Palla Pharma Ltd. manufactures and produces narcotic raw material for the international pharmaceutical industry. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-08-13. The firm's primary activities include production and distribution of Narcotic Raw Material (NRM),Active Pharmaceutical Ingredients (API) and Finished Dosage Formulations (FDF) for supply to international pharmaceutical markets, and the production and distribution of poppy seed for supply to international culinary markets. The firm operates through two segments: Australia and Norway. Australia segment activities include Narcotic Raw Material and Poppy Seed production and distribution. Norway segment activities include Active Pharmaceutical Ingredient and Finished Dosage production and distribution. The firm has developed a water-based extraction technology, which is used in NRM production. The company sources its raw materials from Australian poppy growers in Tasmania, New South Wales, and Victoria.
See Also
What is Palla Pharma Ltd's Revenue?
Revenue
16.8m
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Revenue amounts to 16.8m AUD.
What is Palla Pharma Ltd's Revenue growth rate?
Revenue CAGR 5Y
32%
Over the last year, the Revenue growth was -58%. The average annual Revenue growth rates for Palla Pharma Ltd have been -24% over the past three years , 32% over the past five years .
